Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Extended Survival and Reduced Risk of AML Progression in Erythroid-Responsive Lenalidomide-Treated Patients With Lower-Risk Del(5q) MDS

Leukemia

English

Chemoimmunotherapy With GA101 Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Comorbidity: Results of the CLL11 (BO21004) Safety Run-In

English

Benefit of Continuous Treatment for Responders With Newly Diagnosed Multiple Myeloma in the Randomized FIRST Trial

English

JAK2V617F-mutant Megakaryocytes Contribute to Hematopoietic Stem/Progenitor Cell Expansion in a Model of Murine Myeloproliferation

English

Front-Line Therapies for Elderly Patients With Transplant-Ineligible Multiple Myeloma and High-Risk Cytogenetics in the Era of Novel Agents

English

Constitutively Active MyD88/CD40 Costimulation Enhances Expansion and Efficacy of Chimeric Antigen Receptor T Cells Targeting Hematological Malignancies

English

Disruption of the 5S RNP–Mdm2 Interaction Significantly Improves the Erythroid Defect in a Mouse Model for Diamond-Blackfan Anemia

English

Quantifying Ultra-Rare Pre-Leukemic Clones via Targeted Error-Corrected Sequencing

English

Augmented Efficacy With the Combination of Blockade of the Notch-1 Pathway, Bortezomib and Romidepsin in a Murine MT-1 Adult T-Cell Leukemia Model

English

Enasidenib, an Inhibitor of Mutant IDH2 Proteins, Induces Durable Remissions in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Hematology

Extended Survival and Reduced Risk of AML Progression in Erythroid-Responsive Lenalidomide-Treated Patients With Lower-Risk Del(5q) MDS

Chemoimmunotherapy With GA101 Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Comorbidity: Results of the CLL11 (BO21004) Safety Run-In

Benefit of Continuous Treatment for Responders With Newly Diagnosed Multiple Myeloma in the Randomized FIRST Trial

JAK2V617F-mutant Megakaryocytes Contribute to Hematopoietic Stem/Progenitor Cell Expansion in a Model of Murine Myeloproliferation

Front-Line Therapies for Elderly Patients With Transplant-Ineligible Multiple Myeloma and High-Risk Cytogenetics in the Era of Novel Agents

Constitutively Active MyD88/CD40 Costimulation Enhances Expansion and Efficacy of Chimeric Antigen Receptor T Cells Targeting Hematological Malignancies

Disruption of the 5S RNP–Mdm2 Interaction Significantly Improves the Erythroid Defect in a Mouse Model for Diamond-Blackfan Anemia

Quantifying Ultra-Rare Pre-Leukemic Clones via Targeted Error-Corrected Sequencing

Augmented Efficacy With the Combination of Blockade of the Notch-1 Pathway, Bortezomib and Romidepsin in a Murine MT-1 Adult T-Cell Leukemia Model

Enasidenib, an Inhibitor of Mutant IDH2 Proteins, Induces Durable Remissions in Older Patients With Newly Diagnosed Acute Myeloid Leukemia